| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/23/1992 | WO1992011866A1 LAMININ SEQUENCE AS tPA ACTIVATOR |
| 07/23/1992 | WO1992011865A1 Use of human igf-i |
| 07/23/1992 | WO1992011838A1 Utilization of a growth factor in a slimming composition |
| 07/23/1992 | WO1992008792A3 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 07/23/1992 | WO1992005266A3 Packaging cells |
| 07/23/1992 | CA2100565A1 Insulin analogs |
| 07/23/1992 | CA2100252A1 Amylase-electrolyte oral rehydration method and apparatus |
| 07/23/1992 | CA2099257A1 Use of human igf-1 |
| 07/23/1992 | CA2076848A1 Modified hepatocytes and uses therefor |
| 07/22/1992 | EP0495721A1 Use of a polypeptide having human interleukin-2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax |
| 07/22/1992 | EP0495639A1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 07/22/1992 | EP0495638A2 Expression of mature PDGF-B in Escherichia coli |
| 07/22/1992 | EP0495131A1 Agent for preventing and treating hepatitis |
| 07/22/1992 | EP0495064A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 07/22/1992 | EP0495052A1 Allergens of alder pollen and applications thereof |
| 07/22/1992 | EP0495050A1 Granulocyte-inhibiting polypeptide |
| 07/22/1992 | EP0495049A1 Process for the enzymatic preparation of basic fibroblast growth factor. |
| 07/22/1992 | EP0495047A1 Stable hemoglobin based composition and method to store same. |
| 07/22/1992 | EP0495014A1 Novel oxidized lipoproteins and methods for their preparation |
| 07/22/1992 | EP0494992A1 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 07/22/1992 | EP0494916A1 Feed additive for poultry and poultry feed. |
| 07/22/1992 | EP0451206A4 Receptor transcription-repression activity compositions and methods |
| 07/22/1992 | EP0327548B1 Glycopeptide antibiotics |
| 07/22/1992 | CA2034618A1 Synthetic peptide derived from human lipocortin v and use thereof |
| 07/21/1992 | US5132408 Polypeptides |
| 07/21/1992 | US5132407 Purified inducible nitric oxide synthase flavoprotein |
| 07/21/1992 | US5132406 Method of producing immunoglobulin preparations for intravenous injection |
| 07/21/1992 | US5132403 Forms complex with interleukin-6 receptor; genetic engineering |
| 07/21/1992 | US5132401 MB-35 a peptide enhancing the production of growth hormone and prolactin from the anterior pituitary |
| 07/21/1992 | US5132400 Peptides containing a (1-amino-2-hydroxy-2-heterocyclic)ethyl moiety |
| 07/21/1992 | US5132292 Treatment of viral hepatitis |
| 07/21/1992 | US5132288 Method for controlling Salmonella enteritidis in poultry |
| 07/21/1992 | US5132287 Methods of treating disorders which cause conglutinin deficiency |
| 07/21/1992 | US5132286 Composition of antibiotic l 17054 and a method for the treatment of bacterial infections using the antibiotic |
| 07/21/1992 | US5132214 Large scale production of plasminogen activator from normal human colon cells |
| 07/21/1992 | US5132212 Scl gene, and a hematopoietic growth and differentiation factor encoded thereby |
| 07/21/1992 | US5132109 Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof |
| 07/21/1992 | CA1305439C Production of human lysozyme |
| 07/21/1992 | CA1305417C Stable formulations of ricin toxin a chain and of rta-immunoconjugates and stabilizer screening methods therefor |
| 07/21/1992 | CA1305416C Method of isolating ca 125 antigen |
| 07/21/1992 | CA1305414C Process for preparing an improved composition of the zinc salt of bacitracin for veterinary use as growth promoter |
| 07/21/1992 | CA1305413C Process for producing a coagulation active complex of factor viii fragments |
| 07/19/1992 | WO1992013097A1 Hepatic growth factor receptor is the met proto-oncogene |
| 07/18/1992 | CA2100876A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 07/18/1992 | CA2100579A1 Cell ablation using trans-splicing ribozymes |
| 07/18/1992 | CA2076380A1 Compositions to improve survival of biological materials |
| 07/18/1992 | CA2059512A1 Use of polypeptide having human interleucine 2 activity for the preparation of pharmaceutical compositions useful in the treatment of pneumothorax |
| 07/15/1992 | WO1992012174A1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 07/15/1992 | EP0494776A1 Method of altering the metabolic state of non-dividing cells and obtained transgenic animals |
| 07/15/1992 | EP0494702A2 Production of factor XIIIa by gene technology |
| 07/15/1992 | EP0494664A1 Human bFGF derivatives, their analogs and process for their production |
| 07/15/1992 | EP0494515A1 Antibiotic cyclic hexapeptide |
| 07/15/1992 | EP0494405A2 Use of thiazolidine-4-carboxylate derivatives for the treatment of pulmonary diseases |
| 07/15/1992 | EP0494265A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region |
| 07/15/1992 | EP0494256A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress |
| 07/15/1992 | EP0494248A1 Anti-thrombotic peptides and pseudopeptides |
| 07/15/1992 | EP0494244A1 Therapeutic ribozyme compositions and expression vectors |
| 07/15/1992 | EP0494228A1 Ribozymzusammensetzungen und deren verwendung |
| 07/15/1992 | EP0494175A1 Compositions for cell adhesion inhibition and methods of use |
| 07/15/1992 | EP0413792B1 Products containing a lithium salt and a tumour necrosis factor |
| 07/15/1992 | EP0358709B1 Diabetic control by combined insulin forms |
| 07/15/1992 | EP0357773B1 Process for preparing liposomes |
| 07/15/1992 | EP0261239B1 Fsh-releasing peptide |
| 07/15/1992 | EP0202298B1 Wound healing agents |
| 07/15/1992 | EP0162067B1 Production of factor viii and related products |
| 07/15/1992 | CN1062764A Method for preparation of antibody materials |
| 07/15/1992 | CN1062735A T-butyloxycarbonyl-l-tyrosyl-peptidoglycan monomer and 125 i-labelled derivative thereof, their preparation and use |
| 07/15/1992 | CN1062729A Novel amino and nitro containing tricyclic compounds useful as inhibitors of ace |
| 07/15/1992 | CN1017449B Superoxide dismutase derivatives, method of producing the same and medicinal uses of the same |
| 07/15/1992 | CN1017436B Peptide containing immunoexcitant |
| 07/15/1992 | CA2100549A1 Ligand growth factors that bind to the erbb-2 receptor protein and induce cellular responses |
| 07/14/1992 | US5130418 Method to stabilize basic fibroblast growth factor |
| 07/14/1992 | US5130414 Isolation and structural elucidation of the cyclic peptide hymenistatin 1 |
| 07/14/1992 | US5130337 Aging of proteins by reaction with glucose or other reducing sugar |
| 07/14/1992 | US5130333 Method for treating type II diabetes employing a cholesterol lowering drug |
| 07/14/1992 | US5130324 2-alkylidene-aminoguanidines and methods of use therefor |
| 07/14/1992 | US5130319 Pharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridines |
| 07/14/1992 | US5130307 Antibody inhibitors; treating organ graft rejection, fungal infections; antiinflammatory agents |
| 07/14/1992 | US5130300 Method for enhancing growth of mammary parenchyma |
| 07/14/1992 | US5130299 Method for enhancing growth of mammary parenchyma |
| 07/14/1992 | US5130298 Stabilized compositions containing epidermal growth factor |
| 07/14/1992 | US5130255 Containers that prevent adducts with aldehydes |
| 07/14/1992 | US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals |
| 07/14/1992 | US5130244 Thrombin with disaccharides and arginine |
| 07/14/1992 | US5130143 Use of a low affinity-heparin fraction in conjunction with t-pa for thrombolytic therapy |
| 07/14/1992 | US5130137 Urogenital disorders |
| 07/14/1992 | US5130130 Tumors as target cell for diagnosis |
| 07/14/1992 | US5130129 Method for enhancing antibody transport through capillary barriers |
| 07/14/1992 | US5130128 Hyperimmunized against antigens found in honey |
| 07/14/1992 | US5130123 Dentifrice |
| 07/14/1992 | CA1305287C Inhibitor peptides |
| 07/14/1992 | CA1305286C 1,3,4,-thiadiazoles |
| 07/14/1992 | CA1305175C2 N-t-butoxycarbonyl-(s)-3-amino-(r)-2-hydroxy-4- phenylbutyronitrile and its production process |
| 07/14/1992 | CA1305084C Polypeptides with fibronectin activity |
| 07/14/1992 | CA1305053C Synthetic polymeric drugs |
| 07/14/1992 | CA1305051C Solubilization of proteins for pharmaceutical compositions using polyproline conjugation |
| 07/12/1992 | WO1992011870A1 Method of preventing inflammatory damage |
| 07/12/1992 | WO1992011853A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 07/12/1992 | CA2100351A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 07/12/1992 | CA2100084A1 Method of preventing inflammatory damage |